Capital Growth Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$30.5M |
| 2 |
AMN Healthcare
AMN
|
+$29.7M |
| 3 |
SLB Ltd
SLB
|
+$27.1M |
| 4 |
Halliburton
HAL
|
+$18.6M |
| 5 |
Boston Properties
BXP
|
+$16.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prudential Financial
PRU
|
+$41.8M |
| 2 |
Cleveland-Cliffs
CLF
|
+$37M |
| 3 |
Alcoa
AA
|
+$36M |
| 4 |
MetLife
MET
|
+$34.8M |
| 5 |
Companhia Siderúrgica Nacional
SID
|
+$32.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 37.32% |
| 2 | Real Estate | 26.94% |
| 3 | Consumer Discretionary | 10.47% |
| 4 | Healthcare | 9.75% |
| 5 | Materials | 7.53% |
Similar funds
Capital Growth Management's Q2 2022 Portfolio in Review
As of Q2 2022, Capital Growth Management held 88 positions worth $841M, down 22% from $1.08B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Capital Growth Management withdrew a net $106M in Q2 2022, closing 23 positions and reducing 15 holdings. Its most notable exit was Prudential Financial, an estimated $41.8M position sold in full.
By sector, the portfolio is most concentrated in Energy at 37% of assets, up from 27% a quarter earlier, followed by Real Estate and Consumer Discretionary.
Against the trend, Capital Growth Management opened a new position in Citigroup worth $28.1M.
- Capital Growth Management's largest Q2 2022 buy was Citigroup: 610,000 shares worth $28.1M.
- Capital Growth Management added most to Halliburton in Q2 2022, an estimated $18.6M increase.
- Capital Growth Management's biggest Q2 2022 reduction was Peabody Energy, cutting an estimated $29M.
- Capital Growth Management fully exited Prudential Financial in Q2 2022, selling an estimated $41.8M.
- Capital Growth Management's ten largest holdings make up 38% of its $841M portfolio in Q2 2022.
- Capital Growth Management opened 39 new positions and closed 23 in Q2 2022.
- Capital Growth Management's portfolio value fell 22% quarter-over-quarter to $841M.
Based on Capital Growth Management's 13F filing for Q2 2022, filed 12 Aug 2022.